Search results
Results from the WOW.Com Content Network
In 2020, Perez joined Bolt Biotherapeutics as its Chief Medical Officer. [4] [5] Prior to joining Bolt, she worked as the Vice President and Head of the BioOncology-U.S. Medical Affairs unit at Genentech from 2015 to 2018, where she led the development and conduct of translational studies with registrational intent, including engaging in discussions with the FDA.
Genentech is a pioneering research-driven biotechnology company [14] that has continued to conduct R&D internally as well as through collaborations. [20] [21] Genentech's research collaborations include: In 2008 Genentech entered into a collaboration with Roche and its subsidiary GlycArt to develop obinutuzumab. [22]
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
The U.S. Food and Drug Administration had granted accelerated approval to Gavreto in 2020 for treating patients aged 12 years and above with advanced or metastatic RET-mutant medullary thyroid ...
oncology: Opdivo 7570 5763 6 pembrolizumab: oncology: Keytruda 7171 3809 7 etanercept: rheumatoid arthritis: Enbrel 7126 7885 8 trastuzumab: breast cancer: Herceptin 6981 7013 9 bevacizumab: colon cancer: Avastin 6847 6686 10 rituximab: non-Hodgkin's lymphoma: Rituxan, MabThera 6750 7298 11 rivaroxaban: anticoagulant: Xarelto 6589 6234 12 ...
The Mayo Clinic Cancer Center is one of the oldest NCI-designated cancer centers in the United States, having first been designated in 1973. [3] The main location of the Mayo Clinic is in Rochester, MN. Campuses in Arizona and Florida opened later and became part of the Mayo Clinic Cancer Center in 2003. [4] [5]
Robert A. Kyle is a professor of medicine, Laboratory Medicine and Pathology at the Mayo Clinic.He specializes in the care of patients with plasma cell dyscrasias. . Throughout his career Kyle has published more than 1,850 scientific papers and abstracts on myeloma and other plasma cell diso
Consumer Reports' flagship website and magazine publishes reviews and comparisons of consumer products and services based on reporting and results from its in-house testing laboratory and survey research center. CR accepts no advertising, pays for all the products it tests, and as a nonprofit organization has no shareholders.